DaVita Inks $55 Million Settlement In Epogen FCA Suit
By Juan-Carlos Rodriguez ( July 3, 2012, 11:58 AM EDT) -- Kidney care provider DaVita Inc. said Monday it had reached a $55 million settlement agreement in a qui tam False Claims Act suit alleging it fraudulently billed the federal government for free supplies of Amgen Inc.'s anemia drug Epogen....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.